Ex vivo expansion of human cord blood Lin-CD34-cells using indian hedgehog stromal cells
Ex vivo expansion of human cord blood Lin-CD34-cells using indian hedgehog stromal cells
批准号:
17591003
负责人:
KOBUNE Masayoshi
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
造血干细胞(HSC)的移植通常基于静脉注射,这是一个复杂的过程,需要通过血液循环,通过骨髓血管系统识别和外渗,并迁移到支持性微环境。然而,包括CB Lin-CD 34-干细胞在内的一些HSC很少在骨髓中植入。在TPO、FL和SCF存在下,我们将CB Lin-CD 34-细胞与人基质细胞共培养。结果,共培养的CB Lin-CD 34-细胞显著表达具有显著增殖潜力的趋化因子受体CXCR 4,尽管CB Lin-CD 34-细胞在无基质游离培养的情况下经历凋亡(总细胞,92±10 vs. 1542±161(x10^3); CD 34+细胞,0±0 vs. 156±16(x10^3); CFU-C,192±46 vs. 120320±34762 ; CFU-Mix,8±5 vs. 6513±3791,来自五十万CB Lin-CD 34-细胞)。此外,这些细胞获得了对BM的归巢活性,并在NOD/SCID/IL 2 R_链缺失小鼠中移植24周,尽管在没有人基质细胞的情况下培养的Lin-CD_(34)-细胞几乎不能移植。因此,基质与CB Lin-CD 34-细胞的相互作用赋予了植入BM龛的能力和对造血生长因子的反应性。这些发现可能为骨髓移植和利用CB Lin-CD 34-组分体外生产血细胞提供新的策略。
英文摘要
Transplantation of hematopoietic stem cells (HSCs) is usually based on intravenous injection, a complex process that requires circulation through blood, recognition and extravasation through bone marrow vasculature, and migration to a supportive microenvironment. However, some of HSCs including CB Lin-CD34- stem cells rarely engraft in bone marrow. We cocultured CB Lin-CD34- cells with human stromal cells in the presence of TPO, FL and SCF. As a result, cocultured CB Lin-CD34- cells remarkably expressed chemokine receptor CXCR4 with remarkable proliferative potential although CB Lin-CD34- cells undergo apoptosis without stromal free culture (Total cells, 92±10 vs. 1542±161(x10^3) ; CD34+ cells, 0±0 vs. 156±16 (x10^3) ; CFU-C, 192±46 vs. 120320±34762 ; CFU-Mix, 8±5 vs. 6513±3791 from five hundred thousand CB Lin-CD34- cells). Moreover, these cells acquired homing activity to BM and engrafted in NOD/SCID/IL2R _chain null mice for 24 weeks although Lin-CD34- cells cultured without human stromal cells hardly engrafted. Therefore, stromal interaction with CB Lin-CD34- cells confers the ability of engraftment to BM niche and responsiveness to hematopoietic growth factors. These findings may provide novel strategy of BM transplantation and utilization of CB Lin-CD34- fraction for ex vivo production of blood cells.
期刊论文(17)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Expansion of CD34+ cells on telomerized human stromal cells without losing erythroid-differentiation potential in a serum-free condition
在无血清条件下在端粒化人基质细胞上扩增 CD34+ 细胞而不丧失红系分化潜能
DOI:
--
发表时间:
2005
期刊:
Int.J Hematol. 81,No 1
影响因子:
--
作者:
[Masayoshi Kobune]
通讯作者:
Masayoshi Kobune
DOI:
10.1016/j.exphem.2007.03.005
发表时间:
2007-06-01
期刊:
EXPERIMENTAL HEMATOLOGY
影响因子:
2.6
作者:
[Kato, Junji, Kobune, Masayoshi, Niitsu, Yoshiro]
通讯作者:
Niitsu, Yoshiro
DOI:
10.1016/j.ymthe.2004.09.020
发表时间:
2005-01-01
期刊:
MOLECULAR THERAPY
影响因子:
12.4
作者:
[Kurozumi, K, Nakamura, K, Hamada, H]
通讯作者:
Hamada, H
三輪血液病学
三和血液学
DOI:
--
发表时间:
2005
期刊:
影响因子:
--
作者:
[共同執筆 浅野茂隆, 池田康夫, 内山卓]
通讯作者:
内山卓
Human mesenchymal stem cells xenografted directly to rat liver differentiated into human hepatocytes without fusion.
人间充质干细胞直接异种移植至大鼠肝脏,无需融合即可分化为人肝细胞。
DOI:
--
发表时间:
2005
期刊:
Blood 106
影响因子:
--
作者:
[Sato Y, Kato J, Takayama T, Niitsu Y, et al.]
通讯作者:
et al.
共 9 条
Establishment of iron chelation therapy to inhibit the development of MDS
-
批准号:24659466
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2012
-
负责人:KOBUNE Masayoshi
-
依托单位:
Development of dual targeting therapy for cancer stem cells and niche
-
批准号:21591213
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2009
-
负责人:KOBUNE Masayoshi
-
依托单位:
海外基金